Biotech Execs Promote Biomedical R&D At White House Meeting
At meeting led by NIH Director Collins, participants talked about importance of biomedical research and need for partnerships between industry, government and academia.
You may also be interested in...
Funding from the US National Institutes of Health is a vital source for biomedical research and pharmaceutical pipelines in turn – but biopharma companies have been largely silent on the matter.
Onmibus funding bill would increase NIH funding by $2 billion, including $120 million increase for Precision Medicine Initiative; antibiotic resistance and Alzheimer's research also slated for increase.
Drug industry executives discuss drug pricing and tax and regulatory reform in a high-profile meeting with President Trump at the White House.